Literature DB >> 29310882

High Incidence of Recurrent Ulceration and Major Amputations Associated With Charcot Foot.

Fredrik A Nilsen1, Marius Molund2, Kjetil H Hvaal3.   

Abstract

Few studies have evaluated the long-term clinical outcomes of Charcot foot. The present study evaluated the long-term effects of Charcot foot in a population treated with early weightbearing in a removable Charcot restraint orthotic walker. A retrospective study of 62 consecutive patients (74 feet) treated for Charcot foot from January 2003 to March 2014 was conducted. Of the 74 affected feet, 48 (64.9%) had developed an ulcer. The total amputation rate was 25.7% (19 feet), and 11 feet (14.9%) underwent major amputations. The mortality rate was 19.4% (12 patients). Low Short-Form 36-item scores for all subcomponents were found. The major amputation rate was significantly greater for hindfoot than for midfoot manifestations. Charcot foot results in a high risk of chronic ulceration. The hindfoot Charcot manifestation was associated with a high rate of major amputations. Early weightbearing in a Charcot restraint orthotic walker as treatment of Charcot foot was not supported by the results from the present study.
Copyright © 2017 The American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amputation; complication; conservative treatment; diabetes mellitus; foot ulcer; weightbearing

Mesh:

Year:  2018        PMID: 29310882     DOI: 10.1053/j.jfas.2017.10.008

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  5 in total

1.  Charcot Arthropathy of Foot and Ankle: Radiographic and Clinical Patterns with Related Outcomes.

Authors:  Hani El-Mowafi; Mohamed Abdelaziz Elghazy; Yasser R Kandil; Samer Ali; Ahmed El-Hawary; Mazen S Abulsaad
Journal:  Int Orthop       Date:  2021-05-28       Impact factor: 3.075

2.  Midterm Fate of the Contralateral Foot in Charcot Arthropathy.

Authors:  Felix W A Waibel; Martin C Berli; Viviane Gratwohl; Kati Sairanen; Dominik Kaiser; Laura Shin; David G Armstrong; Madlaina Schöni
Journal:  Foot Ankle Int       Date:  2020-07-22       Impact factor: 2.827

3.  Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?

Authors:  Rachel H Albright; Robert M Joseph; Dane K Wukich; David G Armstrong; Adam E Fleischer
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

4.  Foot ulcer recurrence, plantar pressure and footwear adherence in people with diabetes and Charcot midfoot deformity: A cohort analysis.

Authors:  R Keukenkamp; T E Busch-Westbroek; R Barn; J Woodburn; S A Bus
Journal:  Diabet Med       Date:  2020-11-03       Impact factor: 4.359

5.  Long-term follow-up of conservative treatment of Charcot feet.

Authors:  Viviane Gratwohl; Thorsten Jentzsch; Madlaina Schöni; Dominik Kaiser; Martin C Berli; Thomas Böni; Felix W A Waibel
Journal:  Arch Orthop Trauma Surg       Date:  2021-04-07       Impact factor: 2.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.